Sangeetha Balaji

Sangeetha Balaji

Auto-generated profile, based on publicly available information

Sangeetha Balaji

Department of Regenerative Medicine, Agathisha Institute of Stemcell and Regenerative Medicine (AISRM), Chennai, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2024 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
NJNaveen Jeyaraman
Naveen Jeyaraman
SRSwaminathan Ramasubramanian
Swaminathan Ramasubramanian
SBSangeetha Balaji
Sangeetha Balaji
ANArulkumar Nallakumarasamy
Arulkumar Nallakumarasamy
Filippo MiglioriniFilippo Migliorini
Filippo Migliorini
Musculoskeletal disorders encompass a wide range of conditions that impact the bones, joints, muscles, and connective tissues within the body. Despite the ongoing debate on toxicity and administration, ozone demonstrated promise in managing several musculoskeletal disorders, modulating pain and inflammation. A literature search was conducted. The research design, methods, findings, and conclusions of the studies were then examined to evaluate the physiological effects, clinical application, controversies, and safety of the application of ozone in musculoskeletal medicine. Ozone application demonstrates considerable therapeutic applications in the management of musculoskeletal disorders, including fractures, osteoarthritis, and chronic pain syndromes. Despite these advantages, studies have raised concerns regarding its potential toxicity and emphasized the importance of adhering to stringent administration protocols to ensure safety. Additionally, heterogeneities in patient reactions and hazards from oxidizing agents were observed. Given its anti-inflammatory and analgesic qualities, ozone therapy holds potential in the management of several musculoskeletal disorders. Additional high-quality research with long follow-up is required to refine indications, efficacy and safety profile. Finally, for wider clinical acceptability and utilization, the development of international recommendations is essential.

12 December 2024 in Medical Sciences
Verified
Journal Article
Open access
PDF file
AMAnandanarayan Muruganandam
Anandanarayan Muruganandam
Filippo MiglioriniFilippo Migliorini
Filippo Migliorini
NJNaveen Jeyaraman
Naveen Jeyaraman
Raju VaishyaRaju Vaishya
Raju Vaishya
SBSangeetha Balaji
Sangeetha Balaji
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
Rheumatoid arthritis (RA) represents an autoimmune condition impacted by a combination of genetic and environmental factors, with the gut microbiome (GMB) being one of the influential environmental factors. Patients with RA display notable modifications in the composition of their GMB, characterised by decreased diversity and distinct bacterial alterations. The GMB, comprising an extensive array of approximately 35,000 bacterial species residing within the gastrointestinal tract, has garnered considerable attention as a pivotal contributor to both human health and the pathogenesis of diseases. This article provides an in-depth exploration of the intricate involvement of the GMB in the context of RA. The oral–GMB axis highlights the complex role of bacteria in RA pathogenesis by producing antibodies to citrullinated proteins (ACPAs) through molecular mimicry. Dysbiosis affects Tregs, cytokine levels, and RA disease activity, suggesting that regulating cytokines could be a strategy for managing inflammation in RA. The GMB also has significant implications for drug responses and toxicity, giving rise to the field of pharmacomicrobiomics. The composition of the microbiota can impact the efficacy and toxicity of drugs, while the microbiota’s metabolites can influence drug response. Recent research has identified specific bacteria, metabolites, and immune responses associated with RA, offering potential targets for personalised management. However, several challenges, including the variation in microbial composition, establishing causality, accounting for confounding factors, and translating findings into clinical practice, need to be addressed. Microbiome-targeted therapy is still in its early stages and requires further research and standardisation for effective implementation.

14 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NJNaveen Jeyaraman
Naveen Jeyaraman
Filippo MiglioriniFilippo Migliorini
Filippo Migliorini
SMShrideavi Murugan
Shrideavi Murugan
SRSwaminathan Ramasubramanian
Swaminathan Ramasubramanian
SBSangeetha Balaji
Sangeetha Balaji
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
Metamizole, or dipyrone, has been used for decades as a non-narcotic analgesic, providing pain relief from musculoskeletal disorders and antipyretic and antispasmolytic properties. Despite being in use since the 1920s, its mechanism of action still needs to be discovered. Despite causing fewer adverse effects when compared to other analgesics, its harmful effects on the blood and lack of evidence regarding its teratogenicity make the usage of the drug questionable, which has led to it being removed from the drug market of various countries. This narrative review aims to provide a detailed insight into the mechanism of action and efficacy, comparing its effectiveness and safety with other classes of drugs and the safety profile of metamizole.

17 April 2024 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
Filippo MiglioriniFilippo Migliorini
Filippo Migliorini
SBSangeetha Balaji
Sangeetha Balaji
SRSwaminathan Ramasubramanian
Swaminathan Ramasubramanian
TJTarun Jayakumar
Tarun Jayakumar
NJNaveen Jeyaraman
Naveen Jeyaraman

24 August 2024 in Indian Journal of Orthopaedics
Verified
Journal Article
Closed access
PDF file
NJNaveen Jeyaraman
Naveen Jeyaraman
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
Sathish MuthuSathish Muthu
Sathish Muthu
SBSangeetha Balaji
Sangeetha Balaji
SRSwaminathan Ramasubramanian
Swaminathan Ramasubramanian
BPBISHNU PRASAD PATRO
BISHNU PRASAD PATRO

25 August 2025 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
SASaketh Aspvs
Saketh Aspvs
VVVinnisa Nithiakala Vetrivel
Vinnisa Nithiakala Vetrivel
TPT. Priyadarshini
T. Priyadarshini
KSKrishna Subramanyam
Krishna Subramanyam
NHNaofumi Hashiguchi
Naofumi Hashiguchi
SBSangeetha Balaji
Sangeetha Balaji